Table 1 Characteristics of the study group vs. a healthy control
|  | Study Group N = 60 | Healthy Control N = 70 | P value |
|---|---|---|---|
General Characteristics | |||
 Gender (%) | |||
  Women | 58.3 | 67.1 | 0.299 |
  Men | 41.7 | 32.9 | |
 Age (years) mean ± SD | 37.22 ± 12.88 | 37.13 ± 11.65 | 0.885 |
 Occupation (%) | |||
  Retirement/pension | 36.7 | 2.9 | < 0.001 |
  Parental leave | 0 | 2.9 | |
  Unemployed | 10 | 1.4 | |
  Part-time job | 8.3 | 7.1 | |
  Permanent employment | 36.7 | 82.9 | |
  Student | 8.3 | 2.9 | |
 BMI [kg/m2] (%) | |||
  Underweight (BMI < 18.5) | 1.7 | 1.4 | 0.935 |
  Normal weight (BMI 18.5–24.99) | 45 | 45.7 | |
  Overweight (BMI 25–29.99) | 36.7 | 37.1 | |
  Obesity (BMI > 30) | 16.7 | 15.7 | |
  Vitamin D supplementation (%) | 11.7 | 7.1 | 0.378 |
Characteristics of the Study Group | |||
 Age at disease onset (years) mean ± SD | 18.25 ± 13.38 | – | – |
 Duration of the disease (years) mean ± SD | 18.98 ± 15.63 | – | – |
 Number of medications taken mean ± SD | 1.4 ± 0.7 | – | – |
 Type of epilepsy (%) | |||
  Idiopathic | 73.3 |  | – |
  Post-neonatal | 6.7 |  | |
  Post-traumatic | 13.3 | – | |
  Post-operative | 6.7 |  | |
 Seizures (%) | |||
  Yes | 43.4 |  | – |
  No | 56.6 | – | |
 Anti-epileptic medication | |||
  Monotherapy | 53.3 | – | – |
  Polytherapy | 46.7 |  | |
  Mental illnesses and disorders (%) | 23.3 | – | – |